Assessing the economic burden of Alzheimer's disease patients first diagnosed by specialists

BMC Geriatrics

Volumn 16, Issue 1, 2016, Pages

  Kirson, Noam Y ^a   Desai, Urvi ^a   Ristovska, Ljubica ^a   Cummings, Alice Kate G ^a   Birnbaum, Howard G ^a   Ye, Wenyu ^b   Andrews, J Scott ^b   Ball, Daniel ^b   Kahle Wrobleski, Kristin ^b  

^a ANALYSIS GROUP   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Alzheimer's disease; Cost; Medicare; Primary care; Specialist

Indexed keywords

AGED; ALZHEIMER DISEASE; COST; COST OF ILLNESS; EARLY DIAGNOSIS; ECONOMICS; FEMALE; HUMAN; MALE; MEDICARE; PATIENT REFERRAL; PRIMARY HEALTH CARE; PROCEDURES; PSYCHIATRY; PSYCHOLOGICAL AND PSYCHIATRIC PROCEDURES; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COST OF ILLNESS; COSTS AND COST ANALYSIS; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MEDICARE; PRIMARY HEALTH CARE; PSYCHIATRY; PSYCHOLOGICAL TECHNIQUES; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84979681243     PISSN: None     EISSN: 14712318     Source Type: Journal    
DOI: 10.1186/s12877-016-0303-5     Document Type: Article

References (17)

1. National Institute of Neurological Disorders and Stroke: Dementia: Hope Through Research. National Institutes of Health. 2014. http://www.ninds.nih.gov/disorders/dementias/detail-dementia.htm. Accessed 25 Sept 2014.
2. Alzheimer's Association. 2015 Alzheimer's disease facts and figures. http://www.alz.org/facts/downloads/facts-figures-2015.pdf. Accessed 14 May 2015.
3. Gilden DM, Kubisiak JM, Wrobleski KK, Ball DE, Bowman L. Using U.S. Medicare records to evaluate the indirect health effects on spouses: a case study in Alzheimer's disease patients. BMC Health Serv Res. 2014;14:291.
4. Suehs BT, Shah SN, Davis CD, Alvir J, Faison WE, Patel NC, et al. Household members of persons with Alzheimer's disease: health conditions, healthcare resource use, and healthcare costs. J Am Geriatr Soc. 2014;62:435-41.
5. National Alzheimer's Project Act. Public Law 111-375 - JAN. 4, 2011 http://aspe.hhs.gov/daltcp/napa/PLAW-111publ375.pdf. Accessed 4 Jun 2015
6. Department of Health and Human Services. Priority setting for healthcare performance measurement: Addressing performance measure gaps for dementia, including Alzheimer's disease. Final report, October 15, 2014. http://www.qualityforum.org/priority-setting-for-healthcare-performance-measurement-alzheimers-disease.aspx. Accessed 28 March 2016.
7. Geldmacher DS, Kirson NY, Birnbaum HG, Eapen S, Kantor E, Cummings AK, et al. Implications of early treatment among Medicaid patients with Alzheimer's disease. Alzheimers Dement. 2014;10:214-24.
8. Weimer DL, Sager MA. Early identification and treatment of Alzheimer's disease: social and fiscal outcomes. Alzheimers Dement. 2009;5:215-26.
9. Armstrong RA, Lantos PL, Cairns NJ. Overlap between neurodegenerative disorders. Neuropathology. 2005;25:111-24.
10. Borson S, Scanlan JM, Watanabe J, Tu SP, Lessig M. Improving identification of cognitive impairment in primary care. Int J Geriatr Psychiatry. 2006;21:349-55.
11. Mitchell AJ, Meader N, Pentzek M. Clinical recognition of dementia and cognitive impairment in primary care: a meta-analysis of physician accuracy. Acta Psychiatr Scand. 2011;124:165-83.
12. Dall TM, Storm MV, Chakrabarti R, Drogan O, Keran CM, Donofrio PD, et al. Supply and demand analysis of the current and future US neurology workforce. Neurology. 2013;81:470-8.
13. Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res. 2011;46:399-424.
14. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46:1075-9.
15. Barnes DE, Beiser AS, Lee A, Langa KM, Koyama A, Preis SR, et al. Development and validation of a brief dementia screening indicator for primary care. Alzheimers Dement. 2014;10:656-65.
16. Centers for Medicare and Medicaid Services. Preventive visit & yearly wellness exams. https://www.medicare.gov/coverage/preventive-visit-and-yearly-wellness-exams.html. Accessed 28 March 2016.
17. Committee for Medicinal Products for Human Use. Discussion paper on the clinical investigation of medicines for the treatment of Alzheimer's disease and other dementias, European Medicines Agency, 2014, 23 October 2014, EMA/CHMP/539931/2014.